Cargando…

Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma

BACKGROUND AND AIM: Transarterial chemoembolization (TACE) is the standard procedure for treating Barcelona clinic liver cancer (BCLC) stage B hepatocellular carcinoma (HCC). However, it is often carried out in the treatment of BCLC stage 0/A HCC for various reasons. This study aimed to elucidate th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishikawa, Kentaro, Chiba, Tetsuhiro, Ooka, Yoshihiko, Suzuki, Eiichiro, Ogasawara, Sadahisa, Maeda, Takahiro, Yokoyama, Masayuki, Inoue, Masanori, Wakamatsu, Toru, Kusakabe, Yuko, Saito, Tomoko, Tawada, Akinobu, Arai, Makoto, Kanda, Tatsuo, Maruyama, Hitoshi, Imazeki, Fumio, Kato, Naoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940395/ https://www.ncbi.nlm.nih.gov/pubmed/29765560 http://dx.doi.org/10.18632/oncotarget.25108

Ejemplares similares

Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia
por: Ooka, Yoshihiko, et al.
Publicado: (2014)

A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Ogasawara, Sadahisa, et al.
Publicado: (2015)

Impact of Radiofrequency Ablation-Induced Glisson’s Capsule-Associated Complications in Patients with Hepatocellular Carcinoma
por: Wakamatsu, Toru, et al.
Publicado: (2017)

Fatal Diaphragmatic Hernia following Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report and Literature Review
por: Saito, Tomoko, et al.
Publicado: (2015)

Successful Interventional Treatment for Arterioportal Fistula Caused by Radiofrequency Ablation for Hepatocellular Carcinoma
por: Kanogawa, Naoya, et al.
Publicado: (2014)

Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma
por: Ogasawara, Sadahisa, et al.
Publicado: (2016)

Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Successful Treatment of Hepatocellular Carcinoma Complicated by Fanconi Anemia
por: Takahashi, Koji, et al.
Publicado: (2017)

Henoch-Schönlein Purpura Complicated by Hepatocellular Carcinoma
por: Akizue, Naoki, et al.
Publicado: (2017)

Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma
por: Saito, Tomoko, et al.
Publicado: (2014)

Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma
por: Suzuki, Eiichiro, et al.
Publicado: (2014)

Acute Liver Failure in an Antimitochondrial Antibody-Positive 63-Year-Old Man
por: Wakamatsu, Toru, et al.
Publicado: (2012)

Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance
por: Maruyama, Hitoshi, et al.
Publicado: (2018)

Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma
por: Kanogawa, Naoya, et al.
Publicado: (2020)

Successful Resection of Intracranial Metastasis of Hepatocellular Carcinoma
por: Okimoto, Kenichiro, et al.
Publicado: (2013)

Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma
por: Ogasawara, Sadahisa, et al.
Publicado: (2016)

Simultaneous Resection of Disseminated Hepatocellular Carcinoma and Colon Cancer
por: Haga, Yuki, et al.
Publicado: (2013)

Intracranial Metastasis in a Patient with Hepatocellular Carcinoma and Gastric Cancer
por: Tawada, Akinobu, et al.
Publicado: (2014)

Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin
por: Kanda, Tatsuo, et al.
Publicado: (2016)

Long-term administration of Tolvaptan to patients with decompensated cirrhosis
por: Kanayama, Kengo, et al.
Publicado: (2020)

Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Genome-Wide Mapping of Bivalent Histone Modifications in Hepatic Stem/Progenitor Cells
por: Kanayama, Kengo, et al.
Publicado: (2019)

Incidence and hemodynamic feature of risky esophageal varices with lower hepatic venous pressure gradient
por: Maruyama, Hitoshi, et al.
Publicado: (2019)

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma
por: Yokoyama, Masayuki, et al.
Publicado: (2017)

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
por: Maeda, Takahiro, et al.
Publicado: (2019)

Switching to systemic therapy after locoregional treatment failure: Definition and best timing
por: Ogasawara, Sadahisa, et al.
Publicado: (2020)

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
por: Kanzaki, Hiroaki, et al.
Publicado: (2021)

Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
por: Saito, Tomoko, et al.
Publicado: (2013)

Compensating effect of minor portal hypertension on the muscle mass loss-related poor prognosis in cirrhosis
por: Maruyama, Hitoshi, et al.
Publicado: (2017)

Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy
por: Nakamoto, Shingo, et al.
Publicado: (2017)

Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events
por: Kanda, Tatsuo, et al.
Publicado: (2018)

18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis
por: Tawada, Akinobu, et al.
Publicado: (2014)

Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature
por: Haga, Yuki, et al.
Publicado: (2017)

Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study
por: Miksad, Rebecca A., et al.
Publicado: (2019)

Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners
por: Chiba, Tetsuhiro, et al.
Publicado: (2014)

Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
por: Duan, Feng, et al.
Publicado: (2020)

Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: Transarterial Chemoembolization or Hepatic Resection?
por: Jianyong, Lei, et al.
Publicado: (2014)

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Ao, Junjie, et al.
Publicado: (2021)

IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens
por: Miyamura, Tatsuo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5ka47vl08ht0m54hnb3u1lm0ma